Urinary Tract Tuberculosis

Urinary tract tuberculosis (UTTB) is a form of extrapulmonary tuberculosis in which Mycobacterium tuberculosis infects the kidneys, ureters, bladder, or urethra. It is also referred to as genitourinary tuberculosis (GUTB) when the genital organs are involved. UTTB is one of the most common forms of extrapulmonary TB, accounting for up to around a quarter of extrapulmonary TB cases in some series.

The condition typically develops years or even decades after an initial lung infection, when dormant bacteria reactivate and spread through the bloodstream to the urinary tract. Because symptoms are non-specific and closely mimic common urological conditions — particularly recurrent urinary tract infections — diagnosis is frequently delayed, which can lead to irreversible kidney and bladder damage. With early detection and full treatment, the cure rate is approximately 90%.

How it develops

Primary TB infection almost always begins in the lungs. In most people, the immune system contains the bacteria, which remain dormant. In a smaller proportion, bacteria spread through the bloodstream and seed the kidneys, forming granulomas — clusters of immune cells surrounding the bacteria — that may break down over time and shed bacteria into the urine. From the kidneys, TB can spread down the ureters to the bladder and, in some cases, to the genital organs.

The average time from initial infection to urinary tract disease is often more than 20 years. This is why UTTB can appear long after a person has left a high-prevalence area or has no memory of a previous TB exposure. Reactivation is more likely if the immune system becomes weakened — for example by HIV, diabetes, or immunosuppressive medications.

Symptoms

UTTB is an insidious disease — a significant minority of affected people have no symptoms at all, and many others have only mild or intermittent symptoms that are easily attributed to something else. Symptoms may come and go and are often milder than expected for a serious infection, which contributes to delayed diagnosis. When symptoms do occur, they are frequently mistaken for a standard bacterial UTI.

Common symptoms include:

• Lower urinary tract symptoms — urinary frequency, urgency, and burning or pain on urination that do not resolve with standard antibiotics
• Blood in the urine — visible (gross) haematuria in around 10% of cases; microscopic haematuria in around 50%
• Flank or back pain — when the kidneys are significantly affected
• Sterile pyuria — white blood cells in the urine with no bacteria on standard culture; a classic and important finding
• Recurrent "UTIs" with negative standard cultures — one of the most important clinical clues

Constitutional symptoms of TB — fever, night sweats, and weight loss — are less common in isolated UTTB and, when present, often suggest active TB at another site as well.

Seek evaluation if:

• You have persistent urinary symptoms that do not respond to standard antibiotic treatment
• Your urinalysis shows white blood cells but repeated urine cultures are negative
• You have a history of TB or have lived in or travelled to a high-prevalence region

Risk factors

• Living in or originating from a region with high TB prevalence (South Asia, sub-Saharan Africa, Eastern Europe, parts of Latin America)
• Prior history of pulmonary TB or known TB exposure
• Residence or work in high-risk settings such as healthcare facilities, prisons, or shelters
• HIV infection or other causes of immune compromise; diabetes; immunosuppressive medications or prolonged corticosteroids
• Malnutrition or chronic illness
• Close contact with someone with active TB

Complications

Because diagnosis is often significantly delayed, many patients present with established complications. Earlier detection substantially reduces this risk.

• Ureteral strictures — scarring and narrowing of the ureters causing obstruction and hydronephrosis (swelling of the kidney due to blocked urine flow)
• Non-functioning kidney — severe destruction of renal tissue from longstanding infection; this often affects one kidney rather than both, so complete renal failure is not inevitable
• Contracted bladder — the bladder becomes small and stiff, holding much less urine and causing severe frequency and urgency even when only a small amount of urine is present
• Chronic kidney disease — from ongoing inflammation and obstruction
• Hypertension — from renal involvement

Diagnosis

Diagnosing UTTB requires a high index of clinical suspicion, particularly in patients from endemic backgrounds with persistent urological symptoms and negative standard cultures.

• Urine microscopy and culture for Mycobacteria — the diagnostic cornerstone. Three consecutive early-morning urine (EMU) samples collected on separate days are submitted for acid-fast bacilli (AFB) smear — a special stain for TB and related organisms — and mycobacterial culture. Culture is the gold standard but takes 6–8 weeks; sensitivity from three samples is around 80–90%
• Urine PCR (nucleic acid amplification) — faster than culture (results within days) and increasingly used; particularly useful when rapid diagnosis is needed
• Standard urinalysis — typically shows sterile pyuria (white blood cells without bacteria on standard culture) and haematuria; a persistent unexplained finding that should always prompt TB-specific testing in people with relevant risk factors
• Imaging — CT urography or intravenous urography reveals highly characteristic changes including calyceal distortion, ureteral strictures, calcifications, and hydronephrosis in advanced disease
• Cystoscopy — may show characteristic mucosal changes; biopsy can confirm granulomatous inflammation
• Tuberculin skin test (TST) or interferon-gamma release assay (IGRA) — supports prior TB exposure but cannot confirm active urinary TB on its own
• Chest imaging — to assess for concurrent pulmonary TB

If drug-resistant TB is suspected or confirmed, treatment regimens and duration are adjusted accordingly and managed by TB specialists.

Treatment

UTTB is treated with the same standard anti-tuberculosis drug regimens used for pulmonary TB, managed by or in conjunction with an infectious disease or TB specialist.

Standard drug therapy The standard regimen is 6 months of combination therapy:

• Intensive phase (first 2 months): four drugs — isoniazid, rifampicin, pyrazinamide, and ethambutol
• Continuation phase (months 3–6): two drugs — isoniazid and rifampicin

Some guidelines recommend extending treatment to 9 months for complicated or extensive disease. Full adherence to the complete course is essential — stopping early risks treatment failure and the development of drug resistance.

Monitoring during treatment Regular renal imaging during and after treatment is important to detect ureteral strictures early. Paradoxically, strictures can develop or worsen during the early weeks of treatment as inflammation resolves and scar tissue forms — some complications emerge after treatment begins rather than before. Ureteric stenting may be needed to maintain urine flow.

Surgical intervention Surgery is required in a substantial proportion of UTTB patients, most often to manage complications rather than the infection itself:

• Ureteral stenting or reconstruction — for strictures causing obstruction
• Nephrectomy — removal of a non-functioning, severely destroyed kidney
• Bladder augmentation — for severely contracted bladder; relatively rare

FAQ

Is urinary tract tuberculosis contagious? UTTB itself is not spread through urine contact. The primary contagion risk with TB is respiratory, from pulmonary disease. Patients with isolated UTTB and no active lung disease are generally not considered infectious to others.

Can you have urinary TB without ever having had lung TB? Most people with UTTB had a prior lung infection, often subclinical and unrecognised at the time. The urinary disease develops from dormant bacteria that reactivated later. A previous diagnosis of pulmonary TB is not required for UTTB to develop.

Why does urinary TB show sterile pyuria? Standard urine cultures test for common bacteria and will not detect Mycobacterium tuberculosis. White blood cells appear in the urine because the immune system is responding to the TB infection, but the bacteria causing it will only be found with TB-specific tests such as mycobacterial culture or PCR. Persistent unexplained sterile pyuria — particularly in someone with risk factors — should always prompt TB-specific testing.

Related biomarkers

Urinalysis — particularly the finding of sterile pyuria and haematuria — is the primary lab clue that should prompt TB-specific investigation. Mycobacterial urine culture and urine PCR confirm the diagnosis. Creatinine and eGFR track kidney function and the extent of renal involvement throughout the months-long treatment course. Tracking these markers over time in HealthMatters can help document the urinalysis pattern leading to diagnosis, monitor kidney function, and provide a clear record of treatment response to share with your clinician.